£80.67

It has never been this cheap. We have no record of a lower price.

£81 today · cheaper than every other day in the last 3 months

Springer Hodgkin's and Non-Hodgkin's Lymphoma: 131 (Cancer Treatment and Research, 131)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 18 days · 18 data points (no recent data)

Historical
Generating forecast…
£81.80 £80.56 £80.83 £81.10 £81.37 £81.64 £81.91 22 July 2026 26 July 2026 30 July 2026 03 August 2026 08 August 2026
View at Amazon ↗

Price data last checked 73 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 18 days • 2 price levels

Days at Price
Current Price
1 day · current 17 days 0 4 9 13 17 £81 £82 Days at Price

Price Analysis

Most common price: £82 (17 days, 94.4%)

Price range: £81 - £82

Price levels: 2 different prices over 18 days

Description

Over recent years, there has been a dramatic increase in knowledge of the biology of the lymphomas which has been accompanied by the emergence of new treatments that offer both improvements in efficacy and reduction in toxicity. Molecular profiling of tumor tissue and other new advances have led to a better understanding of the genetic basis of lymphoma, identification of new therapeutic targets, and potentially valuable prognostic information. Monoclonal antibody therapies, radioimmunoconjugates and other new agents such as proteosome inhibitors are providing important new treatment options for patients. In this volume, an internationally recognized group of experts provides a comprehensive overview of the biology, pathology, standard treatments, and novel approaches in management of patients across the complex landscape of lymphoma subtypes. Researchers and practitioners alike will welcome this useful summary of the state of the art in this field.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
21 September 2014
Listed Since
01 October 2010

Barcode

No barcode data available

Similar Products You Might Like

Lymphoma: Pathology, Diagnosis and Treatment
86% match

Lymphoma: Pathology, Diagnosis and Treatment

Cambridge University Press

£68.02 04 Aug 2026
Hematopathology in Oncology: 121 (Cancer Treatment and Research, 121)
86% match

Hematopathology in Oncology: 121 (Cancer Treatment and Research, 121)

Springer

£73.85 05 Aug 2026
Malignant Lymphomas: Biology and Treatment: An Update (ESO Monographs)
85% match

Malignant Lymphomas: Biology and Treatment: An Update (ESO Monographs)

Springer

£78.01 08 Aug 2026
Pediatric Lymphomas (Pediatric Oncology)
85% match

Pediatric Lymphomas (Pediatric Oncology)

Springer

£95.74 08 Aug 2026
Malignant Lymphomas and their Management: 16 (Recent Results in Cancer Research, 16)
84% match

Malignant Lymphomas and their Management: 16 (Recent Results in Cancer Research, 16)

Springer

£78.01 05 Aug 2026
Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide
84% match

Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide

Springer

£98.27 08 Aug 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
83% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 12 Aug 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
83% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£76.42 07 Aug 2026
Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)
83% match

Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)

Humana

£108.01 05 Aug 2026
Lymphoma: 115 (Methods in Molecular Medicine, 115)
83% match

Lymphoma: 115 (Methods in Molecular Medicine, 115)

Humana

£107.98 05 Aug 2026
Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)
83% match

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Springer

£114.71 07 Aug 2026
Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)
82% match

Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)

Springer

£112.42 13 Sep 2026
Adult T-cell Leukemia/Lymphoma
82% match

Adult T-cell Leukemia/Lymphoma

Springer

£99.11 08 Aug 2026
Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)
82% match

Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)

Springer

£113.76 17 Oct 2026
Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research
82% match

Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research

Springer

£108.01 06 Aug 2026
Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)
82% match

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Springer

£164.55 07 Aug 2026
Malignant Brain Tumors: State-of-the-Art Treatment
82% match

Malignant Brain Tumors: State-of-the-Art Treatment

Springer

£88.73 08 Aug 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
82% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.05 05 Aug 2026
Pathobiology of Human Germ Cell Neoplasia: 123 (Recent Results in Cancer Research, 123)
82% match

Pathobiology of Human Germ Cell Neoplasia: 123 (Recent Results in Cancer Research, 123)

Springer

£113.93 08 Aug 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
82% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£166.02 07 Aug 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
82% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£149.64 05 Aug 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
82% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 06 Aug 2026
Ocular and Adnexal Lymphoma (Essentials in Ophthalmology)
82% match

Ocular and Adnexal Lymphoma (Essentials in Ophthalmology)

Springer

£86.45 30 Aug 2026
Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
81% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.67 05 Aug 2026